Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
1.250
+0.010 (0.81%)
Nov 20, 2026, 4:00 PM EST - Market closed
Neuronetics Revenue
Neuronetics had revenue of $41.96M in the quarter ending September 30, 2026, with 12.51% growth. This brings the company's total for the last twelve months to $159.76M, up 23.01% year-over-year. In the year 2025, Neuronetics had annual revenue of $149.16M with 99.17% growth. That makes Neuronetics the 19,175th largest company in the world by revenue and 3,011th in the United States.
Revenue (ttm)
$159.76M
Revenue Growth
+23.01%
P/S Ratio
0.75
Revenue / Employee
$242,798
Employees
658
Market Cap
120.60M
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Neuronetics breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 149.16M | 74.27M | 99.17% |
| Dec 31, 2024 | 74.89M | 3.54M | 4.96% |
| Dec 31, 2023 | 71.35M | 6.14M | 9.42% |
| Dec 31, 2022 | 65.21M | 9.89M | 17.89% |
| Dec 31, 2021 | 55.31M | 6.07M | 12.32% |
| Dec 31, 2020 | 49.24M | -13.41M | -21.41% |
| Dec 31, 2019 | 62.66M | 9.88M | 18.72% |
| Dec 31, 2018 | 52.78M | 12.34M | 30.53% |
| Dec 31, 2017 | 40.43M | 6.21M | 18.13% |
| Dec 31, 2016 | 34.23M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Inogen | 355.06M |
| Quanterix | 148.15M |
| Owlet | 112.85M |
| Pulmonx | 88.78M |
| Apyx Medical | 59.57M |
| TriSalus Life Sciences | 46.39M |
| MaxCyte | 34.37M |
| Nyxoah | 32.77M |
STIM News
- 3 days ago - Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 days ago - Neuronetics initiated with an Outperform at William Blair - TheFly
- 11 days ago - Neuronetics 18.75M share Spot Secondary priced at $1.60 - TheFly
- 11 days ago - Neuronetics Announces Pricing of $30 Million Underwritten Public Offering of Common Stock - GlobeNewsWire
- 11 days ago - Neuronetics announces common stock offering, no amount given - TheFly
- 11 days ago - Neuronetics Announces Proposed Public Offering of Common Stock - GlobeNewsWire
- 15 days ago - Neuronetics price target raised to $6 from $5 at B. Riley - TheFly
- 18 days ago - Neuronetics Earnings Call Transcript: Q3 2026 - Transcripts